로딩 중…
StockDiggingStockDigging

OSTEONIC Co., Ltd.

226400· KOSDAQ
₩4,240-3.31%
2026-06-19

Price Chart

OSTEONIC Co., Ltd.-35.85%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap87.61B KRW
Revenue48.77B KRW
Net Income5.63B KRW
Total Assets111.41B KRW
Net Assets70.23B KRW
Employees179
Value
P/E15.55x
P/B1.25x
PEG0.06x
P/S1.80x
EV/EBITDA28.60x
FCF Yield0.37%
Profitability
ROE8.02%
ROA5.06%
Op. Margin6.62%
Revenue Growth35.39%
Earnings Growth248.38%
Financial Health
Debt Ratio158.62%
Total Debt19.14B KRW
FCF323.6M KRW
Cash14.47B KRW
Current Ratio2.18x
Net Debt/EBITDA1.45x
Performance
1Y Return-35.85%
1M Return-23.88%
From 52W High-48.23%
1Y MDD-48.46%
Trading
Volume199,342 shares
Foreign Own.7.92%
Per Share
EPS455 KRW
BPS3,495 KRW

Company Info

CEO 이동원
Employees 179
Founded 2012
HQ 서울특별시 구로구, KR

Osteonick, established in 2012, specializes in the development, manufacturing, and sale of orthopedic implants, and was listed on KOSDAQ in 2018. The company produces metal and biomaterial-based implants across all orthopedic fields, supplying medical devices for the fixation, replacement, and adjustment of fractured bones. It has secured vertically integrated process technology, collaborates with B. Braun, and is pursuing FDA and CE approvals to expand into global markets. Osteonick is headquartered in Guro-gu, Seoul.